StocksRunner logo
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  Headlines  
 
  Updates  
 
 
Aquestive Therapeuti
4.29
+4.63%
 

AQST

 

Aquestive Therapeutics

$ 4.29

 
+$0.19 | +4.63%
 
 
Open
$ 4.27
 
 
MKT CAP
$ 365.93M
 
High
$ 4.44
 
 
VOL
$ 207.86K
 
Low
$ 4.22
 
 
AVG VOL
$ 3.22M
 
 
 

AQST Stock Analysis

Aquestive Therapeutics (AQST) still has no score becuse there is not enough information which allows us to analyze the activity of the company over a period of time
 
 

AQST Total Score

 
 

Strengths

AQST Rewards

 Earnings are forecast to grow

 
 

Chart

 
 

2.65

2.02

1.68

1.14

 
 
1month
3month
6month
1year
 
Total Return
AQST
vs.
S&P500
 

 
1-week Return
-2.05%
 
+0.37%
 
 
5-week Return
+71.60%
 
+5.45%
 
 
10-week Return
+63.74%
 
+9.82%
 
 
 

AQST Risk Level

This Indicator assigning AQST risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
AQST Risk Level
LOW
HIGH

Risk Volatility

 

AQST has Moderate Risk Level

Click here to check what is your level of risk

 

AQST Analysts Opinion

AQST overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information

 
 

Earnings

×
 

Earnings

3.00
 

AQST Earnings Sentiment

 Reported a weak earnings

AQST Earnings Sentiment

 Above analyst estimates

 
 

Rating

×
 

Rating

NA
 
 

Momentum

×
 

Momentum

4.00
 
 

Activity

×
 

Activity

3.00
 
 

Future

×
 

Future

4.00
 

AQST Future Sentiment

 Earnings are forecast to grow

 
 

AQST Analysts Opinion

AQST Analysts opinion is negative and it remained unchanged from the past 3 months

 

AQST Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
75%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
NA
100%
100%
 
On Track
On Track
On Track
 

AQST Street Opinion 

AQST Street view is bullish and have positive views on the near-term outlook

 

AQST Performance Sentiment

Sentiments overview associated with AQST events and the stock performance.
 
75%
25%
Positive
Negative
6 out of 8
events present
2 out of 8
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

AQST Earnings

The TTM reflects 12-month period, providing review of AQST financial performance.

 
Millions of Dollars
TTM
2023
2022
CAGR
 

 
Total Revenue
51
51
48
+3.08%
 
 
Cost of Revenue
21
21
19
+5.13%
 
 
Gross Profit
30
30
28
+3.51%
 
 
Operating Exp
45
45
70
-19.82%
 
 
Operating Inc
-15
-15
-42
-
 
 
Net Interest Inc
9
9
-12
-
 
 
Interest Exp
7
7
12
-23.62%
 
 
Interest Inc
16
16
-
 
 
Other Income
-1
-1
-
-
 
 
EPS
-0.22
-
-1.12
-
 
 
Next Earnings Date: Apr 30, 2024
 
 
Headlines
Last Modify
Price
% Change

 
Weak Earnings
3 Weeks Ago
5.03
+20.05%
 
Strong Earnings
2 Month Ago
2.50
-5.66%
 
 
AQST Latest News +
 
 
StocksRunner

Explore our AQST Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored FDX Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our AQST Daily Alerts

Access the exclusive insights that over 10,000+ subscribers value. Stay ahead in the stock market! Submit your email for daily alerts.

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo

StocksRunner

Get the pulse of the market

 
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 

AQST Rewards

 Earnings are forecast to grow

 
 
 

AQST Risk Level

 
 
 

The Indicator assigning AQST risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
 
AQST Risk Level
LOW
HIGH

Risk Volatility

 

AQST has Moderate Risk Level. Click here to check what is your level of risk

 
 
 
 

Stock Analysis

 
 
 
 

AQST

 

Aquestive Therapeutics

$ 4.29

 
+$0.19 | +4.63%
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  Headlines  
 
  Updates  
 

 
joker
 
 
 
Open
$ 4.27
 
 
MKT CAP
$ 365.93M
 
High
$ 4.44
 
 
VOL
$ 207.86K
 
Low
$ 4.22
 
 
AVG VOL
$ 3.22M
 
 
 

AQST Analysis

Aquestive Therapeutics (AQST) still has no score becuse there is not enough information which allows us to analyze the activity of the company over a period of time
 
 

Chart

 
 

2.65

2.02

1.68

1.14

 
 
1month
3month
6month
1year
 
Total Return
AQST
vs.
S&P500
 

 
1-week Return
-2.05%
 
+0.37%
 
 
5-week Return
+71.60%
 
+5.45%
 
 
10-week Return
+63.74%
 
+9.82%
 
 
 

AQST Analysts Opinion

AQST Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information

 
 

Earnings

×
 

Earnings

3.00
 

AQST Earnings Sentiment

 Reported a weak earnings

AQST Earnings Sentiment

 Above analyst estimates

 
 

Rating

×
 

Rating

NA
 
 

Momentum

×
 

Momentum

4.00
 
 

Activity

×
 

Activity

3.00
 
 

Future

×
 

Future

4.00
 

AQST Future Sentiment

 Earnings are forecast to grow

 
 

AQST Analysts Opinion

AQST Analysts opinion is negative and it remained unchanged from the past 3 months

 

AQST Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
75%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
NA
100%
100%
 
On Track
On Track
On Track
 

AQST Street Opinion 

AQST Street view is bullish and have positive views on the near-term outlook

 
AQST Performance Sentiment
Sentiments overview associated with AQST events and the stock performance.
 
75%
25%
Positive
Negative
6 out of 8
events present
2 out of 8
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

AQST Earnings

The TTM data reflects the most recent 12-month period, providing overview of AQST financial performance.

 
Millions of Dollars
TTM
2023
2022
CAGR
 

 
Total Revenue
51
51
48
+3.08%
 
 
Cost of Revenue
21
21
19
+5.13%
 
 
Gross Profit
30
30
28
+3.51%
 
 
Operating Exp
45
45
70
-19.82%
 
 
Operating Inc
-15
-15
-42
-
 
 
Net Interest Inc
9
9
-12
-
 
 
Interest Exp
7
7
12
-23.62%
 
 
Interest Inc
16
16
-
 
 
Other Income
-1
-1
-
-
 
 
EPS
-0.22
-
-1.12
-
 
 
Next Earnings Date: Apr 30, 2024
 
Headlines
Last Modify
Price
% Change

 
Weak Earnings
3 Weeks Ago
5.03
+20.05%
 
Strong Earnings
2 Month Ago
2.50
-5.66%
 
 
AQST Latest News +
 
 
 
 
 

Score Tracker

 
 
 
Based on 8 events in the last 90 days from financial news and social media. Last updated Mar 28, 2024 10:10 Wall St. time
 
 

AQST Total Score

 
 
 
 
 
 
 
StocksRunner

Discover AQST Stock analysis and effective trading strategies with StocksRunner. Gain valuable insights into stock performance, market trends, and the future potential of AQST. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our AQST Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

AQST Stock trends

AQST Stock performance

AQST Stock analysis

AQST investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
Post ×
 
0/666
joker